Latest Articles
Genmab's Rina-S: A Breakthrough in Endometrial Cancer and a Catalyst for Shareholder Value - AInvest
Genmab's Rina-S: A Breakthrough in Endometrial Cancer and a Catalyst for Shareholder Value AInvest
Published: Aug. 26, 2025, 5:39 p.m.
Innovative Technique for Adolescent Cervical Endometriosis Treatment - BIOENGINEER.ORG
Innovative Technique for Adolescent Cervical Endometriosis Treatment BIOENGINEER.ORG
Published: Aug. 26, 2025, 5:30 p.m.
Innovative Technique for Adolescent Cervical Endometriosis Treatment - bioengineer.org
Innovative Technique for Adolescent Cervical Endometriosis Treatment bioengineer.org
Published: Aug. 26, 2025, 5:30 p.m.
OnlyFans’ Annie Knight ‘Bleeding a Lot’ After Sleeping With 583 Men in 6 Hours - AOL.com
OnlyFans’ Annie Knight ‘Bleeding a Lot’ After Sleeping With 583 Men in 6 Hours AOL.com
Published: Aug. 26, 2025, 4:38 p.m.
Analyzing ImmunityBio Inc. with multi timeframe charts - July 2025 Institutional & Risk Controlled Daily Plans - Newser
Analyzing ImmunityBio Inc. with multi timeframe charts - July 2025 Institutional & Risk Controlled Daily Plans Newser
Published: Aug. 26, 2025, 4:22 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced - PharmiWeb.com
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced PharmiWeb.com
Published: Aug. 26, 2025, 4:10 p.m.
Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer - Curetoday
Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer Curetoday
Published: Aug. 26, 2025, 4:06 p.m.
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches - Frontiers
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches Frontiers
Published: Aug. 26, 2025, 3:55 p.m.
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review - Frontiers
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review Frontiers
Published: Aug. 26, 2025, 3:33 p.m.
Olaparib Maintenance in Advanced Endometrial Cancer Trial - BIOENGINEER.ORG
Olaparib Maintenance in Advanced Endometrial Cancer Trial BIOENGINEER.ORG
Published: Aug. 26, 2025, 3:07 p.m.
Link copied to clipboard!